Arthritis & Rheumatism

Vitamin D3, placebo both improve chronic low back pain

(HealthDay)—For patients with nonspecific chronic low back pain (CLBP), vitamin D3 and placebo offer similar improvements, according to a study published in the November issue of the International Journal of Rheumatic Disease.

Arthritis & Rheumatism

Trimethoprim-induced aseptic meningitis described

(HealthDay)—Drug-induced aseptic meningitis following trimethoprim use has been described in a research letter published online Nov. 20 in the International Journal of Rheumatic Diseases.

Cardiology

The heart of the matter for Indigenous mothers

Indigenous women journeying though pregnancy with the added complication of rheumatic heart disease have the best outcomes with collaborative and culturally appropriate care according to the lead researcher in a four-year ...

Diseases, Conditions, Syndromes

Scarlet fever making a comeback

An international study led by University of Queensland (UQ) researchers has tracked the re-emergence of a childhood disease which had largely disappeared over the past 100 years.

Arthritis & Rheumatism

Biosimilars—clinical perspectives in rheumatology

Universitätsmedizin Berlin and the University of Massachusetts Medical School have been analyzing clinical data on biosimilars that have already been approved for use. The term 'biosimilars' refers to drugs that mimic the ...

Inflammatory disorders

Understanding the genetics of inflammation

The Kennedy Institute of Rheumatology is an international centre of excellence for researching inflammation in the body, from causes to treatments. Professor Irina Udalova is the Institute's principal investigator of the ...

Arthritis & Rheumatism

Weekly leflunomide effective for early rheumatoid arthritis

(HealthDay)—A higher, weekly dose of leflunomide shows similar benefits to a daily dose for the treatment of mild-to-moderate early rheumatoid arthritis (ERA), according to a study published online Aug. 13 in the International ...

Diseases, Conditions, Syndromes

Scientists identify a mechanism of epidemic bacterial disease

Through identification of increased toxin production by epidemic forms of group A streptococcus (the "flesh-eating" bacterium), for the first time scientists are able to pinpoint the molecular events that contribute to large ...

page 19 from 34